Involvement of glucose related energy crisis and endoplasmic reticulum stress: Insinuation of streptozotocin induced Alzheimer's like pathology

被引:36
|
作者
Biswas, Joyshree [1 ]
Gupta, Sonam [2 ,3 ]
Verma, Dinesh Kumar [3 ]
Gupta, Parul [3 ]
Singh, Abhishek [3 ]
Tiwari, Shubhangini
Goswami, Poonam [4 ]
Sharma, Sharad [3 ]
Singh, Sarika [2 ]
机构
[1] UConn Hlth, Neurosci Dept, 263 Farmington Ave, Farmington, CT 06030 USA
[2] Acad Sci & Innovat Res AcSIR, Lucknow 226031, Uttar Pradesh, India
[3] CSIR, Toxicol & Expt Med Div, Cent Drug Res Inst, Lucknow 226031, Uttar Pradesh, India
[4] Jamia Hamdard, Dept Med Elementol & Toxicol, New Delhi 110062, India
关键词
Endoplasmic reticulum stress; Glucose transporters; Donepezil; Acetylcholinesterase activity; Connexin; Apoptosis; NEURODEGENERATIVE DISEASES; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; AMYLOID PLAQUES; RAT-BRAIN; CALCIUM; MEMORY; INSIGHTS; CA2+; NEUROINFLAMMATION;
D O I
10.1016/j.cellsig.2017.10.018
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The present study was conducted to correlate the cellular and molecular alterations in Alzheimer's pathology employing streptozotocin (STZ) induced experimental rat model. The STZ was administered in rat brain bilaterally by intracerebroventricular route using stereotaxic surgery followed by donepezil dosing. The Alzheimer's related pathological marker like acetylcholinesterase (AChE) activity, tau phosphorylation and amyloid aggregation were observed after STZ administration. STZ treatment showed decreased glucose and glucose transporters (GLUT) level along with augmented level of calcium in both cortical and hippocampal regions of rat brain. Increased calcium level may correlate with endoplasmic reticulum (ER) stress and significantly increased expression of ER stress markers like GRP78, GADD and caspase-12 were observed in STZ treated rat brain. Cellular communication was also affected by STZ administration as observed by increased expression connexin 43. With this view the activation of astrocytes and microglia was also assessed and observed by augmented GFAP and cd1 1b expression which were partially inhibited with donepezil treatment. The significantly increased level of degenerating neurons, caspase-3 and DNA fragmentation was also observed in rat brain regions which were not inhibited with donepezil treatment and validating the clinical observations. In conclusion, study indicated the STZ induced occurrence of Alzheimer's pathology. Further, STZ administration also caused depleted glucose level, inhibited mitochondrial activity, augmented calcium levels, ER stress, altered cellular communication and neuronal death which were partially attenuated with donepezil treatment.
引用
收藏
页码:211 / 226
页数:16
相关论文
共 38 条
  • [31] Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits Aβ25-35-induced apoptosis in PC12 cells by suppressing the expression of endoplasmic reticulum stress-related proteins
    Zhang, Jianfeng
    Wu, Junfeng
    Zeng, Weichen
    Zhao, Yongfei
    Zu, Hengbing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (10): : 12784 - 12792
  • [32] Peroxiredoxin 1 inhibits streptozotocin-induced Alzheimer's disease-like pathology in hippocampal neuronal cells via the blocking of Ca2+/Calpain/Cdk5-mediated mitochondrial fragmentation
    Park, Junghyung
    Won, Jinyoung
    Yang, Eunyeoung
    Seo, Jincheol
    Cho, Jiyeon
    Seong, Jung Bae
    Yeo, Hyeon-Gu
    Kim, Keonwoo
    Kim, Yu Gyeong
    Kim, Minji
    Jeon, Chang-Yeop
    Lim, Kyung Seob
    Lee, Dong-Seok
    Lee, Youngjeon
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [33] Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior
    Sharma, Sheetal
    Verma, Sonia
    Kapoor, Monika
    Saini, Avneet
    Nehru, Bimla
    NEUROLOGICAL RESEARCH, 2016, 38 (09) : 838 - 850
  • [34] Limettin and PD98059 Mitigated Alzheimer’s Disease Like Pathology Induced by Streptozotocin in Mouse Model: Role of p-ERK1/2/p-GSK-3β/p-CREB/BDNF Pathway
    Rofida M. Hassan
    Nesrine S. Elsayed
    Naglaa Assaf
    Barbara Budzyńska
    Krystyna Skalicka-Wożniak
    Sherehan M. Ibrahim
    Journal of Neuroimmune Pharmacology, 20 (1)
  • [35] Involvement of the activation of Nrf2/HO-1, p38 MAPK signaling pathways and endoplasmic reticulum stress in furazolidone induced cytotoxicity and S phase arrest in human hepatocyte L02 cells: modulation of curcumin
    Dai, Chongshan
    Lei, Lei
    Li, Bin
    Lin, Yang
    Xiao, Xilong
    Tang, Shusheng
    TOXICOLOGY MECHANISMS AND METHODS, 2017, 27 (03) : 165 - 172
  • [36] Ischemia-like Oxygen and Glucose Deprivation Mediates Down-regulation of Cell Surface γ-Aminobutyric AcidB Receptors via the Endoplasmic Reticulum (ER) Stress-induced Transcription Factor CCAAT/Enhancer-binding Protein (C/EBP)-homologous Protein (CHOP)
    Maier, Patrick J.
    Zemoura, Khaled
    Acuna, Mario A.
    Yevenes, Gonzalo E.
    Zeilhofer, Hanns Ulrich
    Benke, Dietmar
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (18) : 12896 - 12907
  • [37] Neuromodulatory effect of vardenafil on aluminium chloride/d-galactose induced Alzheimer’s disease in rats: emphasis on amyloid-beta, p-tau, PI3K/Akt/p53 pathway, endoplasmic reticulum stress, and cellular senescence
    Heba H. Awad
    Mahmoud A. Desouky
    Alaa Zidan
    Mariam Bassem
    Amaal Qasem
    Mona Farouk
    Haidy AlDeab
    Miral Fouad
    Cherry Hany
    Nada Basem
    Rita Nader
    Ashrakat Alkalleny
    Verina Reda
    Mina Y. George
    Inflammopharmacology, 2023, 31 : 2653 - 2673
  • [38] Neuromodulatory effect of vardenafil on aluminium chloride/d-galactose induced Alzheimer's disease in rats: emphasis on amyloid-beta, p-tau, PI3K/Akt/p53 pathway, endoplasmic reticulum stress, and cellular senescence
    Awad, Heba H.
    Desouky, Mahmoud A.
    Zidan, Alaa
    Bassem, Mariam
    Qasem, Amaal
    Farouk, Mona
    AlDeab, Haidy
    Fouad, Miral
    Hany, Cherry
    Basem, Nada
    Nader, Rita
    Alkalleny, Ashrakat
    Reda, Verina
    George, Mina Y.
    INFLAMMOPHARMACOLOGY, 2023, 31 (05) : 2653 - 2673